UNSPECIFIED (2006) Modelling the impact of prison vaccination on hepatitis B transmission within the injecting drug user population of England and Wales. VACCINE, 24 (13). pp. 2377-2386. doi:10.1016/j.vaccine.2005.11.055

Research output not available from this repository, contact author.

Request Changes to record.

Abstract

A vaccination programme offering hepatitis B (HBV) vaccine at reception into prison has been introduced into selected prisons in England and Wales. The work here considers the impact of prison vaccination on the incidence and prevalence of hepatitis B virus (HBV) in the injecting drug user (IDU) population of England and Wales. A dynamic model of the transmission of HBV in IDUs is developed with key model assumptions and parameters being subject to sensitivity analyses.

The base case model (that assumes that the vaccination coverage on prison reception is 5% in 2002, 10% in 2003 and then increases linearly up to 50% of prison receptions being vaccinated by 2006) predicts that the incidence of HBV in IDUs might be reduced by almost 80% in 12 years, and the HBV prevalence (IDUs ever infected by HBV) may be reduced from approximately 18% in 2002 to 7% in 2015.

The model presented here demonstrates that HBV vaccination on prison reception can have a significant impact on the prevalence and incidence of HBV in the IDU population over time. (c) 2005 Elsevier Ltd. All rights reserved.

Item Type:	Journal Article
Subjects:	Q Science > QR Microbiology > QR180 Immunology R Medicine
Journal or Publication Title:	VACCINE
Publisher:	ELSEVIER SCI LTD
ISSN:	0264-410X
Official Date:	20 March 2006
Dates:	Date Event 20 March 2006 UNSPECIFIED
Volume:	24
Number:	13
Number of Pages:	10
Page Range:	pp. 2377-2386
DOI:	10.1016/j.vaccine.2005.11.055
Publication Status:	Published

Data sourced from Thomson Reuters' Web of Knowledge

Request changes or add full text files to a record

Repository staff actions (login required)

View Item